Price Prediction: Rocket Lab’s Next Leg Higher Could Be Massive, 95% Upside Ahead
Rocket Lab's stock has been hammered over the past month even as its backlog swells and a transformative acquisition looms, and that tension between near-term pain and long-term potential is exactly where the most interesting price setups tend to emerge.
My 24/7 Wall St. price target for Rocket Lab (NASDAQ:RKLB | RKLB Price Prediction) is $120.99, versus a current price of $61.96. That implies roughly 95.3% upside over the next 12 months and supports a buy rating with a 50% confidence level.
Confidence sits at moderate because Neutron’s first flight and the Iridium deal are binary events that can materially shift the trajectory in either direction.
24/7 Wall St. Price Target Summary
| Metric | Value |
|---|---|
| Current Price | $61.96 |
| 24/7 Wall St. Price Target | $120.99 |
| Upside | 95.3% |
| Recommendation | BUY |
| Confidence Level | 50% |
Where the Stock Sits After a Volatile Summer
Rocket Lab has been anything but quiet. Shares are down 22.6% over the past month and 11.2% year to date, yet still up 34.2% over the past year and 231.5% over five years. The stock sits well off its 52-week high of $151, but comfortably above its 52-week low of $37.57.
Fundamentals continue to firm. Q2 FY2026 revenue reached a record $234 million, up 62% year over year, backlog grew to $2.36 billion, and non-GAAP gross margin expanded to 41.5% from 36.9%. CEO Peter Beck called the launch environment extreme, noting customers are locking in Neutron slots because “launch has never been so constrained.”
Bull Case: A Path to $156 and Beyond
The bull thesis is straightforward: Rocket Lab is compounding backlog, expanding margins, and stacking transformative catalysts. Beck’s team signed more than $1 billion in new contracts straddling Q2 and early Q3, including a $397M Flatellite award, a $816M Space Development Agency Tracking Layer contract, and selection for the $17.9 billion Golden Dome program alongside Raytheon.
Neutron, with an ASP of $50 million to $55 million, is targeting Q4 2026 delivery to the pad, and Beck says he has “zero issues in selling full price neutrons pre-test flights.” Layer in the pending Iridium deal, which brings 2.5 million subscribers and $870 million in annual revenue, and the bull-case path to $156 looks well grounded.
What Could Go Wrong
Valuation is stretched. Rocket Lab trades at a price-to-sales ratio of 52.4, and the company remains unprofitable, with a Q2 GAAP net loss of $49.3 million and a FY2025 free cash flow of -$321.8M. Dilution has been meaningful: $1.08 billion was raised through the ATM in Q2 alone.
Neutron’s timeline has already slipped once after a Stage 1 tank test failure. It should be noted, however, that bulls would argue the current losses reflect deliberate investment in Neutron, GHOST, and three simultaneous acquisitions, all of which management expects to drive significant free cash flow once integrated.
If Neutron slips into 2027 and integration stumbles, the bear-case path lands near $94.84.
How Rocket Lab Stacks Up Against ASTS and Kratos
AST SpaceMobile (NASDAQ:ASTS) is the natural new-space comp: another pre-profitability satellite operator with a $17.96 billion market cap, $150M to $200M in 2026 revenue guidance, and a $1.30 billion backlog. Rocket Lab’s $2.36 billion backlog and diversified launch plus space systems revenue makes RKLB’s setup materially more mature at similar risk profile.
Kratos Defense (NASDAQ:KTOS) is the hypersonic and defense-tech contrast that overlaps with HASTE’s end market. Kratos has posted a -40.7% year-to-date return, worse than RKLB’s -18.5%, suggesting the market is already awarding Rocket Lab a scarcity premium. Against these peers, our $120.99 target looks reasonable rather than aggressive.
Rocket Lab Price Prediction 2026-2030
The 24/7 Wall St. price target of $120.99 reflects a buy with moderate confidence. The tipping factor is backlog quality: $2.36 billion combined with a Golden Dome seat and Iridium optionality gives RKLB rare visibility.
I’d be a buyer here if Neutron reaches the pad in Q4 2026 and Q3 revenue lands inside the $250M to $265M guide. I’d stay on the sidelines if Neutron slips past mid-2027 or if Iridium regulatory approval stalls.
| Year | 24/7 Wall St. Price Target |
|---|---|
| 2026 | $120.99 |
| 2027 | $197.33 |
| 2028 | $265.97 |
| 2029 | $338.75 |
| 2030 | $384.70 |
These projections assume Rocket Lab scales Neutron to a full cadence, closes Iridium on schedule, and continues to win Space Force and SDA awards. Significant upside or downside could result from Neutron ASP expansion or a delay to the Golden Dome buildout.
Contact [email protected] for any questions or corrections.
Vandita Jadeja is a financial publisher with over a decade of experience writing about financial topics, including investment, savings, retirement, insurance and banking. Vandita is a Chartered Accountant who loves to debunk financial concepts for readers.
Her work has appeared on sites that include The Motley Fool, InvestorPlace, and Benzinga. She covers investing and focuses on stock picks and price prediction for 24/7 Wall St.
When not looking for the next stock investment opportunity, she can be found traveling, reading, chasing sunsets and enjoying her iced latte.
